schizandrin b has been researched along with Ovarian Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, SY; Ju, RJ; Kong, L; Li, XT; Liu, XZ; Liu, Y; Zang, J; Zhang, L | 1 |
1 other study(ies) available for schizandrin b and Ovarian Neoplasms
| Article | Year |
|---|---|
The anti-ovarian cancer effect of RPV modified paclitaxel plus schisandra B liposomes in SK-OV-3 cells and tumor-bearing mice.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell-Penetrating Peptides; Cyclooctanes; Female; Humans; Lignans; Liposomes; Mice; Mice, Inbred BALB C; Ovarian Neoplasms; Paclitaxel; Polycyclic Compounds; Xenograft Model Antitumor Assays | 2021 |